Eyenovia
Eyenovia strives to create drug therapies that are more effective, safer, and smarter than traditional eyedroppers. Eyenovia was founded in 2014 and is based in New York, the United States.
Last updated on
About Eyenovia
Founded
2014Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$63MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
New York CityState
New YorkCountry
United StatesTech Stack (86)
